Conjunctival Findings in Patients With Coronavirus Disease 2019

Zhe Liu,Qing Xiao,Chuan-bin Sun
DOI: https://doi.org/10.1001/jamaophthalmol.2020.5813
IF: 8.253
2021-02-01
JAMA Ophthalmology
Abstract:<span><strong>To the Editor</strong> We read with interest the article of Wu et al<sup><a class="ref-link section-jump-link" href="#ele200015r1">1</a></sup> on the characteristics of ocular findings in patients with novel coronavirus disease (COVID-19). Wu et al<sup><a class="ref-link section-jump-link" href="#ele200015r1">1</a></sup> reported that ocular manifestations consistent with conjunctivitis were found in 12 of 38 patients (31.6%) with COVID-19 and concluded that ocular abnormalities frequently occurred in patients with more severe COVID-19 and acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be transmitted via the eyes. However, we consider that the conjunctivitis Wu et al<sup><a class="ref-link section-jump-link" href="#ele200015r1">1</a></sup> described in their article may not be caused by SARS-CoV-2 infection, ophthalmic involvement may not be associated with the severity of COVID-19, and the eye is not likely to play as a transmission route of SARS-CoV-2 infection, based on previous investigations and the findings of Wu et al.<sup><a class="ref-link section-jump-link" href="#ele200015r1">1</a></sup></span>
ophthalmology
What problem does this paper attempt to address?